Genetic Disease Testing
Payments companies reported to CMS as associated with Genetic Disease Testing. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Genetic Disease Testing, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Genetic Disease Testing
These are the largest totals companies reported as associated with Genetic Disease Testing. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Donald Basel | Milwaukee, WI | Clinical Genetics (M.D.) | $8,400.00 |
| Donald Gilbert | Cincinnati, OH | Neurology With Special Qualifications In Child Neurology | $3,123.00 |
| David Lanfear | Detroit, MI | Cardiovascular Disease | $3,085.68 |
| Wendy Chung | Boston, MA | Clinical Genetics (M.D.) | $2,529.68 |
| Danielle Nolan | Royal Oak, MI | Neurology With Special Qualifications In Child Neurology | $2,475.00 |
| Nicholas Marston | Boston, MA | Cardiovascular Disease | $1,828.00 |
| Peter Hulick | Evanston, IL | Clinical Genetics (M.D.) | $122.99 |
| Wesley Patterson | Greenwood, SC | Physician Assistant | $122.99 |
| Abdallah Elias | Helena, MT | Clinical Genetics (M.D.) | $122.99 |
| Michael Lyons | North Charleston, SC | Clinical Genetics (M.D.) | $122.99 |
Prescribed Genetic Disease Testing?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.